ES8603500A1 - Procedimiento para la preparacion de nuevos derivados de triazolopirimidina. - Google Patents

Procedimiento para la preparacion de nuevos derivados de triazolopirimidina.

Info

Publication number
ES8603500A1
ES8603500A1 ES542583A ES542583A ES8603500A1 ES 8603500 A1 ES8603500 A1 ES 8603500A1 ES 542583 A ES542583 A ES 542583A ES 542583 A ES542583 A ES 542583A ES 8603500 A1 ES8603500 A1 ES 8603500A1
Authority
ES
Spain
Prior art keywords
opt
substd
alkylene
alkyl
heterocyclyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES542583A
Other languages
English (en)
Other versions
ES542583A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Publication of ES8603500A1 publication Critical patent/ES8603500A1/es
Publication of ES542583A0 publication Critical patent/ES542583A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/081,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/40Unsubstituted amino or imino radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/50Nitrogen atoms bound to hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE DERIVADOS DE TRIAZOLOPIRIMIDINA Y DE SUS SALES FISIOLOGICAMENTE COMPATIBLES, DE FORMULA (I), EN LA QUE A REPRESENTA CH O NITROGENO; Y X Y R PUEDEN SER VARIOS TIPOS DE RADICALES. CONSISTE EN LA REACCION DE DIAZOTACION DE UN COMPUESTO DE FORMULA (II), EN LA QUE TODOS LOS SIMBOLOS TIENEN EL MISMO SIGNIFICADO QUE EN LA FORMULA (I), O UNA SAL DEL MISMO, POR TRATAMIENTO CON UN NITRITO EN UN ACIDO O CON UN ESTER DE ACIDO NITROSO. LA DIAZOTACION SE EFECTUA CON AL MENOS, UNA CANTIDAD EQUIMOLECULAR DE NITRITO Y UN GRAN EXCESO DE ACIDO, ENFRIANDO CON HIELO, A UNA TEMPERATURA COMPRENDIDA ENTRE 1JC Y 30JC. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS PARA EL TRATAMIENTO Y PROFILAXIS DE ENFERMEDADES ALERGICAS.
ES542583A 1984-04-25 1985-04-25 Procedimiento para la preparacion de nuevos derivados de triazolopirimidina. Granted ES542583A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59083232A JPS60226887A (ja) 1984-04-25 1984-04-25 トリアゾロピリミジン誘導体

Publications (2)

Publication Number Publication Date
ES8603500A1 true ES8603500A1 (es) 1985-12-16
ES542583A0 ES542583A0 (es) 1985-12-16

Family

ID=13796575

Family Applications (1)

Application Number Title Priority Date Filing Date
ES542583A Granted ES542583A0 (es) 1984-04-25 1985-04-25 Procedimiento para la preparacion de nuevos derivados de triazolopirimidina.

Country Status (19)

Country Link
US (1) US4652646A (es)
EP (1) EP0159707B1 (es)
JP (1) JPS60226887A (es)
KR (1) KR920002133B1 (es)
AT (1) ATE49765T1 (es)
AU (1) AU580050B2 (es)
CA (1) CA1250836A (es)
DE (1) DE3575562D1 (es)
DK (1) DK181985A (es)
ES (1) ES542583A0 (es)
FI (1) FI81585C (es)
GR (1) GR850995B (es)
IL (1) IL75012A (es)
MX (1) MX8232A (es)
NO (1) NO170584C (es)
PH (1) PH21387A (es)
PT (1) PT80346B (es)
YU (1) YU44048B (es)
ZA (1) ZA853113B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL85207A (en) * 1987-02-06 1992-06-21 Daiichi Seiyaku Co 6-substituted thiazolo-(and 1,3,4-thiadiazolo-)(3,2-a)-(1,2,3)triazolo(4,5-d)pyrimidin-9(1h)-ones and their preparation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1338235A (en) * 1970-12-15 1973-11-21 May & Baker Ltd Azapurinones
US4223031A (en) * 1978-05-05 1980-09-16 Mead Johnson & Company Azolopyrimidinones
US4366156A (en) * 1979-03-05 1982-12-28 Mead Johnson & Company Antiallergic methods using diazaheterocyclopurines

Also Published As

Publication number Publication date
FI81585C (fi) 1990-11-12
KR920002133B1 (ko) 1992-03-12
JPS60226887A (ja) 1985-11-12
FI851617L (fi) 1985-10-26
CA1250836A (en) 1989-03-07
EP0159707B1 (en) 1990-01-24
AU580050B2 (en) 1988-12-22
DK181985A (da) 1985-10-26
PT80346A (en) 1985-05-01
DE3575562D1 (de) 1990-03-01
PT80346B (pt) 1987-06-17
US4652646A (en) 1987-03-24
GR850995B (es) 1985-11-25
IL75012A (en) 1988-12-30
KR850007602A (ko) 1985-12-07
AU4164085A (en) 1985-10-31
FI81585B (fi) 1990-07-31
NO170584B (no) 1992-07-27
JPH0421676B2 (es) 1992-04-13
YU44048B (en) 1990-02-28
FI851617A0 (fi) 1985-04-24
PH21387A (en) 1987-10-15
IL75012A0 (en) 1985-08-30
ATE49765T1 (de) 1990-02-15
DK181985D0 (da) 1985-04-23
NO170584C (no) 1992-11-04
YU69385A (en) 1987-10-31
ZA853113B (en) 1985-12-24
EP0159707A3 (en) 1986-10-22
NO851654L (no) 1985-10-28
EP0159707A2 (en) 1985-10-30
MX8232A (es) 1993-12-01
ES542583A0 (es) 1985-12-16

Similar Documents

Publication Publication Date Title
DK108491A (da) Nucleosider og nucleosidanaloge samt farmaceutiske praeparater indeholdende disse forbindelser
ES8201166A1 (es) Un procedimiento para preparar un solvato solido del acido sin-7-(2-(2-amino-4-tiazolil)-2-metoximino)-acetamido-3-acetoximetil-3-cefem-4-carboxilico
IL97538A0 (en) Liposomes containing an aminoglycoside salt and their preparation
JPS6479184A (en) Pyrazolotriazine derivative
UA41865C2 (uk) Сполуки цефему, що мають антимікробну активність, та фармацевтична композиція, що їх містить
NZ228632A (en) Topical otopathic preparations containing ofloxacin
IE851241L (en) Cephalosporins and analogues thereof
ES8201583A1 (es) Un procedimiento para la preparacion de derivados de triazo-lopiridazina
MY101126A (en) Novel compounds
ES8603500A1 (es) Procedimiento para la preparacion de nuevos derivados de triazolopirimidina.
GB1315439A (en) Ergoline derivatives
MY102954A (en) Carbapenem antibiotics
DE3272896D1 (en) Aminocyclopentane esters and their preparation and pharmaceutical formulation
ES8604970A1 (es) Procedimiento para la obtencion de compuestos de 2-heterociclil-alquilo inferior-2-penem
EP0288888A3 (en) Novel glucopyranose derivatives
JPS5236684A (en) Process for preparation of novel penicillins and cephalosporins
ATE177104T1 (de) Cephalosporinderivative
ES8604556A1 (es) Procedimiento para preparar derivados de flaveno y tioflave-no
ES8801835A1 (es) Procedimiento para la obtencion de compuestos de 2-heterociclil-6-hidroxi-alquilo inferior-2-penem
EP0410652A3 (en) Improvement of excretion of potassium ion by prostanoic acid derivatives
EP0219666A3 (en) Cyclopentane derivatives
ES8604158A1 (es) Procedimiento para la obtencion de iminosulfonamidas
GB1268815A (en) Improvements in or relating to phloroglucinol derivatives
ES8800930A1 (es) Un metodo de preparacion de un compuesto de oxodiazina
PL324070A1 (en) Novel compounds of ellipticin, method of obtaining them and pharmaceutical preparations containing such compounds

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970303